Allspring Global Investments Holdings, LLC - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 54 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$2,015
-93.8%
176
-96.0%
0.00%
Q4 2022$32,729
-96.5%
4,453
-96.6%
0.00%
-100.0%
Q3 2022$937,000
-19.5%
130,189
-4.8%
0.00%0.0%
Q2 2022$1,164,000
+670.9%
136,797
+711.3%
0.00%
Q1 2022$151,000
+81.9%
16,862
+179.8%
0.00%
Q4 2021$83,0006,0270.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders